Hydroxyurea and sickle cell anemia: effect on quality of life

BACKGROUND: The Multicenter Study of Hydroxyurea (HU) in Sickle Cell Anemia (MSH) previously showed that daily oral HU reduces painful sickle cell (SS) crises by 50% in patients with moderate to severe disease. The morbidity associated with this disease is known to have serious negative impact on th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ballas, Samir K, Barton, Franca B, Waclawiw, Myron A, Swerdlow, Paul, Eckman, James R, Pegelow, Charles H, Koshy, Mabel, Barton, Bruce A, Bonds, Duane R
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2006
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1569824/
https://ncbi.nlm.nih.gov/pubmed/16942629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7525-4-59
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados